Bonus Material-22_Critical Care Pearls_Quill_2025

Pdf Summary

This critical care summary by Dr. Caroline M Quill focuses on key ICU management topics: analgesia and sedation, delirium, cardiac life support, and supportive care.<br /><br />Analgesia and sedation: Pain affects 50-90% of ICU patients and increases stress hormones, hyperglycemia, immune suppression, PTSD, and chronic pain. Self-reporting is the gold standard for pain assessment; tools like CPOT and BPS aid non-communicative patients. Protocolized, assessment-driven pain management is recommended. Common ICU opioids include morphine, hydromorphone, fentanyl, and remifentanil, each with unique side effects. Adjuncts such as ketamine, α2-agonists (dexmedetomidine), and gabapentinoids have roles. Sedation should favor light levels using non-benzodiazepines (propofol, dexmedetomidine) over benzodiazepines due to better outcomes and less delirium. Daily sedation interruption ("SAT") and targeting light sedation help shorten ventilation duration and ICU stay.<br /><br />Delirium: An acute, often under-recognized confusional state linked to increased mortality, prolonged ICU/hospital stay, and long-term cognitive impairment. Risk factors include dementia, hypertension, alcoholism, and severity of illness. Benzodiazepines elevate delirium risk. Delirium subtypes include hyperactive and hypoactive, with the latter being most common but harder to detect. Prevention centers on non-pharmacologic strategies—promoting sleep hygiene, early mobilization, and implementing the ABCDEF (A2F) bundle. Pharmacologic treatment has limited benefit; antipsychotics may be used cautiously for safety but do not improve mortality. Dexmedetomidine is preferred over benzodiazepines for sedation in delirious patients requiring sedation.<br /><br />Cardiac life support: Emphasis on high-quality CPR with minimal interruptions, adequate depth and rate, and full recoil. Post-cardiac arrest care includes targeted temperature management (TTM) between 32-36°C for at least 24 hours to improve neurologic outcomes, avoiding fever during rewarming. Extracorporeal CPR (ECPR) offers benefit in select patients. Pharmacologic interventions (eg, epinephrine) should be timely to minimize myocardial injury.<br /><br />Speed round supportive care: Transfuse RBCs when hemoglobin <7 g/dL except in ischemic heart disease. Platelet transfusions thresholds depend on bleeding risk. Glycemic control targets <180 mg/dL to avoid hypoglycemia. Renal replacement therapies (continuous or intermittent) are equivalent; continuous preferred in unstable patients. Pharmacologic DVT prophylaxis, preferably with LMWH, is recommended. Stress ulcer prophylaxis with PPIs reduces GI bleeding in ventilated patients. Early enteral nutrition within 48-72 hours using protocols facilitates recovery. Status epilepticus should be promptly treated with benzodiazepines followed by second-line agents.<br /><br />Overall, the lecture stresses protocol-driven ICU management emphasizing analgesia, sedation, delirium prevention, high-quality resuscitation, and evidence-based supportive therapies to optimize critical care outcomes.

Meta Tag

Concept Delirium

Concept Cardiac Arrest

Concept Cardiopulmonary Resuscitation

Concept ICU analgesia

Concept ICU Sedation

Keywords

ICU management

analgesia

sedation

delirium

cardiac life support

CPR

targeted temperature management

supportive care

pain assessment

dexmedetomidine

Delirium

Cardiac Arrest

Cardiopulmonary Resuscitation

ICU analgesia

ICU Sedation